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Objectives: In this study, we compared between the efﬁcacy and complications of percutaneous neph-
rostomy (PCN) tubes and those of internal ureteral stents (e.g., double-J stents) used for relieving ureteral
obstructions.
Materials and methods: A retrospective chart review was performed. Between 2003 and 2009, 110
patients (63 females and 47 males, with a mean age of 63.6 years, range 19e89 years) who had an
extrinsic ureteral obstruction, and subsequently underwent either PCN tube placement (n ¼ 44) or
internal ureteral stent placement (n ¼ 66), were enrolled. Clinical data on patients with duration of
diversion/drainage for more than 6 months were collected. Statistical analyses were performed with
respect to a patient’s age, etiology of the obstruction, outcome of residual hydronephrosis, and renal
function tests.
Results: Patient ages and procedure-related complications were comparable between these two groups.
The mean duration of diversion was 16.8  8.6 months in the stent group versus 14.1  6.7 months in the
PCN group (p ¼ 0.067). A smaller elevation in serum creatinine was noted in the PCN group (0.21 vs.
0.78 mg/dL, p ¼ 0.03). Nine of 86 (10.4%) double-J stents were converted to PCN tubes during the study
period. Residual hydronephrosis after decompression was more common in the stent group than in the
PCN group (65.2% vs. 27.2%, p ¼ 0.01). These ﬁndings suggest better preservation of renal function by
a PCN tube.
Conclusions: Results of this study suggest that, to better preserve renal function, PCN is the choice of
treatment, irrespective of the etiology. While patients who have a PCN tube may have to carry an
additional external drainage device, the complications did not seem to differ signiﬁcantly from those
who used internal drainage with a ureteral stent. Because young cancer patients may especially need
aggressive chemotherapy to prolong their survival, PCN urinary drainage may become a better choice
from the standpoint of cancer control.
Copyright  2012, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Urinary diversion is one of the ways to manage ureteral
obstructions and is commonly performed in our daily practice
when the underlying condition of ureteral obstruction cannot be
eliminated in a short period. Ureteral obstructions can be a conse-
quence of malignancies or benign diseases. Once ametastatic lesion
affects a ureter, the resultant obstruction is very difﬁcult to cure and
should therefore be drained. The approach of draining urine, thetment of Surgery, Tri-Service
Section 2, Neihu, Taipei 114,
).
ciation. Published by Elsevier Taiwso-called urinary diversion, can be either the use of an internal
ureteral stent (e.g., a double-J stent) or a percutaneous neph-
rostomy (PCN). Although both the approaches preserve renal
function, they differ in many aspects.
Clear guidelines regarding optimal urinary diversions have not
been established. Most authors agreed that decisions should be
individualized.1 Retrograde implantation of ureteral stents is
associated with a high failure rate in patients with an obstruction
secondary to a malignancy.2,3 Such patients ultimately require PCN
procedures to drain the affected kidney. However, it is reasonable
that a large portion of patients will initially refuse the PCN proce-
dure, because of the need to carry an external urine-collecting bag.4
It is pivotal to preserve the long-term renal function in young
patients with ureteral obstruction, since they have a long lifean LLC. Open access under CC BY-NC-ND license.
Table 1
Patient characteristics.
Variable Ureteral
stent
Percutaneous
nephrostomy
p
Total (n) 66 44
Mean age (y) 60.8 67.8 0.043
Age 65 y (n, %) 24 (36.4) 26 (59.1)
Age <65 y (n, %) 42 (63.6) 18 (40.9)
Gender (n, %)
Male 25 (37.9) 22 (50)
Female 41 (62.1) 22 (50)
Laterality (n, %) 0.22
Left 23 (34.8) 14 (31.8)
Right 23 (34.8) 14 (31.8)
Both 20 (30.4) 16 (36.4)
Duration of diversion
(mean  SD mo)
16.8  8.6 14.1  6.7 0.067
Stricture level (n)
Upper 17 13
Middle 5 13
Lower 44 18
SD ¼ standard deviation.
Table 2
Primary cause of ureteral obstruction.
Ureteral stent Percutaneous nephrostomy
Benign causes 40 16
Malignancy 26 28
Cervical cancer 19 9
Prostate cancer 4 5
Colon cancer 1 7
Bladder cancer 2 1
Stomach cancer 0 1
Ovarian cancer 0 1
Lung cancer 0 1
Endometrial cancer 0 1
Lymphoma 0 1
Breast cancer 0 1
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a malignancy, optimal renal function is a prerequisite for aggressive
treatments such as chemotherapy.
The true efﬁcacies of PCN tubes and double-J stents were not
clearly compared in the previous studies. We believe that obtaining
these data will help establish a good rationale to approach these
cases.
2. Materials and methods
A retrospective chart review was performed. Between 2003 and
2009, 110 patients (47 males and 63 females; 86 stents and 60 PCN
tubes) were enrolled in a single institute. Enrollment criteria con-
sisted of the need for unilateral or bilateral upper urinary tract
diversion for at least 6 months. Either a PCN tube or an internal
ureteral stent (e.g., double-J stent) was used for ureteral obstruc-
tions of various etiologies. Cases of stone-related hydronephrosis
were excluded from this study.
In the stent group, the obstructed ureters were stentedwith 7-Fr
catheters (InLay ureteral stent; Bard, Covington, GA, USA) under
cystoscopy. In the PCN group, radiologists performed the proce-
dures under ultrasonographic guidance. In all cases, 8-Fr neph-
rostomy catheters were put in place. In our practice, either PCN
tubes or double-J stents were kept for a maximal period of 3
months, and then replacement was required. The tubes were also
replaced when obstructions or infections were observed clinically.
We measured hydronephrosis according to sonographic ﬁnd-
ings using the SFU grading system.5 In our study, any hydro-
nephrosis of no less then grade 1 (i.e., dilated renal pelvis) was
recorded as residual hydronephrosis. The criteria for acute pyelo-
nephritis were met when fever, backache, and a positive urine
culture presented together.
Data on serial serum creatinine levels and adverse events after
both procedures were collected. We also reviewed interval changes
in the severity of hydronephrosis in the study cohort.
Statistical analysis was performed with commercial computer
software (SPSS version 15; SPSS Inc., Chicago, IL, USA). Statistical
signiﬁcance was set at p < 0.05.
3. Results
Patients who received upper urinary tract diversions were aged
19e89 (mean, 63.6) years. We identiﬁed 66 patients (60%) with
ureteral stents and 44 (40%) with PCN tubes. In total, 86 renal units
receiving ureteral stents and 60 renal units receiving PCN tubes
were included in the analysis. The mean duration of diversion was
16.8  8.6 months in the stent group versus 14.1  6.7 months in
the PCN group (p ¼ 0.067).
Gender, laterality, and location of the obstruction/stricture did
not differ in the two groups. The overall age of the two groups
differed signiﬁcantly (60.8 vs. 67.8 years, p ¼ 0.004); younger
patients tended to receive ureteral stenting as the treatment. This
was more obviously noted for patients under 65 years old (Table 1).
Regarding the etiology, 56 cases were of benign causes and 54
were due to a malignancy. Extensive ureteral injury was the most
common cause requiring urinary diversion among the benign
etiologies; cervical cancer was the most common malignancy
associated with ureteral obstructions in the study cohort (Table 2).
Maintaining a stable serum creatinine level and relieving
hydronephrosis were the primary goals of upper urinary tract
diversion. The baseline mean serum creatinine level was higher in
the PCN group than in the stent group (2.96 vs. 1.48 mg/dL,
p ¼ 0.014). We also noted that nine of 86 double-J stents (10.4%)
were converted to PCN tubes because of failure tomaintain patency
or of an associated refractory infection. Cases of conversions werenoted in four of 17 (23.5%) strictures in the upper, zero of ﬁve (0%) in
the middle, and ﬁve of 44 (11.3%) in the lower ureter.
Regarding the efﬁcacy of urinary diversion, a smaller elevation
in the serum creatinine level was observed in the PCN group than in
the stent group (0.78 vs. 0.21 mg/dL, p ¼ 0.003) (Table 3). Residual
hydronephrosis in renal units after the diversion was more
common in the stent group than in the PCN group (65.2% vs. 27.2%,
p ¼ 0.01). The stent group was observed to have more frequent
urinary tract infections, including urosepsis and pyelonephritis,
than the PCN group, but the difference was not statistically
signiﬁcant.
4. Discussion
Ureteral obstruction was highly amenable to endoscopic
ureteral stents in cases of benign intrinsic obstruction, but the
incidence of stent failure was signiﬁcantly higher in cases of
extrinsic compression, as was seen with most malignant diseases.
Retrograde insertion of ureteral stents ultimately failed in 16e58%
of patients whose ureteral obstructions were due to a malignancy.6
Despite previous enthusiasm, metallic stents were also reported to
have considerable failure rates of 38e48%.7 These patients then
required a PCN or ureterostomy to achieve adequate diversion.
Although the severity of hydronephrosis itself is not directly
related to residual renal function, more severe hydronephrosis still
implies higher intrarenal pressure that can hamper renal function.
Table 3
Efﬁcacy of urinary diversion/drainage.
Ureteral stent Percutaneous
nephrostomy
p
Mean initial
creatinine (mg/dL)
1.48 2.96 0.014
Creatinine change (mg/dL) 0.78 (1.8 to 1.2) 0.21 (2.4 to 1.9) 0.03
Residual hydronephrosis 43/66 (65.2%) 12/44 (27.2%) 0.01
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decompressionwas higher in patients who had undergone ureteral
stenting (65.2% vs. 27.2%). A small percentage of patients in the PCN
group had undergone ureteral stenting initially, but eventually
switched to PCN after learning that their renal function had
deteriorated.
Progressive loss of patency after various methods of urinary
diversion was reported by Ku et al,1 who also reported that
morbidities after internal or external diversion were minimal in
cases of malignant obstruction. However, patients scheduled to
receive an internal ureteral stent should be more carefully moni-
tored for ongoing obstruction than those scheduled for PCN tube
placement.1 A greater chance of ongoing obstruction of a ureteral
stent than a PCN tube may explain why the latter was associated
with a less elevated creatinine level. The treatment consensus in
our institute recommends placing bilateral double-J stents or PCN
tubes when bilateral obstructions are diagnosed. Although serum
creatinine may return to normal with unilateral diversion, our goal
is to preserve every kidney whenever possible.
Mechanisms of stent occlusion are not fully delineated, but it is
suspected that impairment of ureteral smooth muscles by extrinsic
ureteral compression and encrustation of the lumen play important
roles.8 Previous studies showed that repeated stent replacement for
a malfunction did occur, on average, 2.8 times in a 90-day period.
Other studies showed similar results for stent failure rates,
including 11% of patients at 2 months and 56% at 3 months due to
obstruction.9 Chung et al10 reported that 44% of patients with
malignant ureteral obstruction had stent failure in their 15-year
experience with management. Despite improvements in tech-
niques and biomaterials, optimal management of malignant
ureteral obstruction remains unclear.11 Progressive urinary
obstruction can lead to renal failure, electrolyte imbalances, and
urinary tract infections. These complications were more commonly
observed in the double-J stent group.
Modern ureteral stents were modiﬁed to improve resistance to
extrinsic compression, cause less bladder irritation and infection,
and offer prolonged effective indwelling periods.4 Long-term
follow-up data on these new stents are still lacking.
McCullough et al reported that the serum creatinine at the
diagnosis of obstructive hydronephrosis could be used to predict
which patients will have retrograde stent placement failure. A
serum creatinine level before retrograde ureteral stent placement
of 1.2 mg/dL is known to be an unfavorable prognostic factor of
overall survival in malignant ureteral obstruction.12 It is therefore
important to prevent, as much as possible, serum creatinine levels
from rising in all patients. Although increases in body muscles,
heart failure, and profound shock may also contribute to elevated
serum creatinine, these factors were not seen in our study
population.
Our current study showed that patients were older in the PCN
group. Elderly patients have long been considered to be at high
risk and to be poor candidates for surgery or chemotherapy.However, since younger cancer patients may need more aggres-
sive chemotherapy to prolong their survival, better preservation
of renal function with PCN may be indicated. On the contrary,
most young patients were put on internal ureteral stents due to
concerns about their quality of life; gradual loss of renal function
of the affected side may become irreversible after long-term
stents in these patients. At that point of time, there would be
no choice but to modify the dose or formula of the
chemotherapy.
A major limitation of our study is the sample size. Secondarily,
the ages and baseline creatinine levels were not completely
matched in these two groups, thereby making comparisons difﬁ-
cult. A randomized, double-blind study should be performed in the
future to make clear suggestions regarding choices between an
internal stent and a PCN tube.5. Conclusions
Urinary diversion or decompression using PCN produced better
preservation of renal function and lower incidences of complica-
tions in our study. For younger cancer patients who may need
aggressive chemotherapy to prolong their survival, even with
normal baseline serum creatinine levels, turning away from long-
term double-J stents and choosing a PCN tube may become more
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